These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34246664)

  • 21. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
    Labrie F; Martel C; Balser J
    Menopause; 2011 Jan; 18(1):30-43. PubMed ID: 20683211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
    Barton DL; Shuster LT; Dockter T; Atherton PJ; Thielen J; Birrell SN; Sood R; Griffin P; Terstriep SA; Mattar B; Lafky JM; Loprinzi CL
    Support Care Cancer; 2018 Apr; 26(4):1335-1343. PubMed ID: 29164377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dehydroepiandrosterone therapy on cognitive performance among postmenopausal women: a systematic review of randomized clinical trial data.
    Sultana F; Davis SR; Islam RM
    Menopause; 2023 Nov; 30(11):1167-1173. PubMed ID: 37788418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.
    Rabijewski M; Papierska L; Binkowska M; Maksym R; Jankowska K; Skrzypulec-Plinta W; Zgliczynski W
    Ginekol Pol; 2020; 91(9):554-562. PubMed ID: 33030737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone status and efficacy of dehydroepiandrosterone supplementation for bone health in anorexia nervosa: A systematic review and meta-analysis.
    Lin J; Kao TW; Cheng YC; Fan KC; Huang YC; Liu CW
    Int J Eat Disord; 2022 Jun; 55(6):733-746. PubMed ID: 35460091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of tibolone treatment on apolipoproteins and lipoprotein (a) concentrations in postmenopausal women: A meta-analysis of randomized controlled trials.
    Li C; Wei M; Mo L; Velu P; Prabahar K; Găman MA; Chen M
    Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():8-16. PubMed ID: 37948929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
    Labrie F; Labrie C
    Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DHEA replacement for postmenopausal women: placebo or panacea?
    Eden JA
    Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
    Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydroepiandrosterone supplementation is not beneficial in the late postmenopausal period in diet-induced obese rats.
    Teixeira CJ; Ribeiro LM; Veras K; da Cunha Araujo LC; Curi R; de Oliveira Carvalho CR
    Life Sci; 2018 Jun; 202():110-116. PubMed ID: 29601891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women.
    Igwebuike A; Irving BA; Bigelow ML; Short KR; McConnell JP; Nair KS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):534-8. PubMed ID: 18029465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of short-term DHEA supplementation on serum and hippocampal estrogen concentrations in perimenopausal female rhesus macaques.
    Urbanski HF; Sorwell KG; Prokai L; Kohama SG
    Neurobiol Aging; 2017 Jul; 55():172-174. PubMed ID: 28431754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.
    Elraiyah T; Sonbol MB; Wang Z; Khairalseed T; Asi N; Undavalli C; Nabhan M; Altayar O; Prokop L; Montori VM; Murad MH
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3536-42. PubMed ID: 25279571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydroepiandrosterone (DHEA) supplementation for cognitive function .
    Huppert FA; Van Niekerk JK
    Cochrane Database Syst Rev; 2001; (2):CD000304. PubMed ID: 11405958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
    Rubino S; Stomati M; Bersi C; Casarosa E; Luisi M; Petraglia F; Genazzani AR
    Maturitas; 1998 Jan; 28(3):251-7. PubMed ID: 9571601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials.
    Li X; Hou X; Hernández-Wolters B; Prabahar K; Kord-Varkaneh H; Mei B
    Exp Gerontol; 2024 Jun; 191():112431. PubMed ID: 38608792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.